Meeting
2019 Genitourinary Cancers Symposium
Preoperative trial of neoadjuvant abiraterone plus or minus cabazitaxel: Early results.
Authors
Jaime Omar Herrera-Caceres
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Jaime Omar Herrera-Caceres , Hanan Goldberg , Aaron Richard Hansen , Srikala S. Sridhar , Robert James Hamilton , Antonio Finelli , Alexandre Zlotta Sr., Anthony M. Joshua , Neil Eric Fleshner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 98)
DOI
10.1200/JCO.2019.37.7_suppl.98
Abstract #
98
Poster Bd #
E22
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols
Poster
2023 ASCO Genitourinary Cancers Symposium
De novo prostate cancer in renal transplant recipients: A single-center study.
First Author: Arthi Sridhar
Poster
2018 Genitourinary Cancers Symposium
Results of a phase II trial of neoadjuvant abiraterone + prednisone+ enzalutamide + leuprolide (APEL) versus enzalutamide + leuprolide (EL) for patients with high-risk localized prostate cancer (PC) undergoing radical prostatectomy (RP).
First Author: Rana R. McKay
Poster
2017 Genitourinary Cancers Symposium
Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
First Author: Adam G. Sowalsky